The drug industry has long paid influential doctors to speak to peers as a way of building word-of-mouth marketing. But such practices can cross the line, legal experts say, when doctors promote uses of the drug that are not approved by the Food and Drug Administration, and when speaking fees are paid in exchange for the doctors’ prescribing behavior. Eric Campbell, professor of medicine at Massachusetts General Hospital, is quoted.
